Dr. Eric Klein on genomic testing for genitourinary cancers

“It’s really fascinating how the field is expanding,” Klein says.

“[Genomic testing is] going to be a routine part of prostate cancer care and urologic cancer care going forward,” Eric A. Klein, MD, says in this video. Klein is the Chairman of the Glickman Urological & Kidney Institute and a staff member in the Taussig Cancer Institute at Cleveland Clinic.

Related Content:

UTvProstate Cancer
Dr. Chin discusses advantages of Zenflow Spring System for BPH
Dr. Loeb on urologists being conscious of their environmental impact
What urologists can do to make their institutions more inclusive